These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris. Marazzi P; Boorman GC; Donald AE; Davies HD J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873 [TBL] [Abstract][Full Text] [Related]
46. Psychological impact of isotretinoin treatment in patients with moderate and severe acne. Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397 [TBL] [Abstract][Full Text] [Related]
47. Isotretinoin and the risk of depression. Thakrar BT; Robinson NJ J Clin Psychiatry; 2009 Oct; 70(10):1475; author reply 1475-6. PubMed ID: 19906352 [No Abstract] [Full Text] [Related]
48. Results of Laboratory Monitoring in Patients Taking Isotretinoin for Acne. Al-Haddab M; Alhuqayl A; Alsharif H; Alolyet D; Altaleb R Cutis; 2021 Jul; 108(1):43-45. PubMed ID: 34397358 [TBL] [Abstract][Full Text] [Related]
49. Include discussions and review of systems regarding inflammatory bowel disease in patients starting isotretinoin therapy: comment on "Isotretinoin therapy and inflammatory bowel disease". Mostow EN Arch Dermatol; 2011 Jun; 147(6):729-30. PubMed ID: 21690538 [No Abstract] [Full Text] [Related]
50. Isotretinoin and night blindness. Teo K; Yazdabadi A Australas J Dermatol; 2014 Aug; 55(3):222-4. PubMed ID: 25117163 [TBL] [Abstract][Full Text] [Related]
52. Could isotretinoin flare hidradenitis suppurativa? A case series. Gallagher CG; Kirthi SK; Cotter CC; Revuz JR; Tobin AMT Clin Exp Dermatol; 2019 Oct; 44(7):777-780. PubMed ID: 30719727 [TBL] [Abstract][Full Text] [Related]
53. The frequency of hematuria in acne vulgaris patients during isotretinoin treatment. Yesilkaya B; Alli N; Artuz RF; Ulu E; Kartal D; Cinar SL Cutan Ocul Toxicol; 2017 Mar; 36(1):74-76. PubMed ID: 26938860 [TBL] [Abstract][Full Text] [Related]
54. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086 [TBL] [Abstract][Full Text] [Related]
55. Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris. Kus S; Gün D; Demirçay Z; Sur H Int J Dermatol; 2005 Mar; 44(3):248-51. PubMed ID: 15807739 [TBL] [Abstract][Full Text] [Related]
56. Isotretinoin-induced pruritic erythematous lesions and acute chest pain in a 15-year-old girl. Alataş ÖD; Alataş ET Am J Emerg Med; 2020 May; 38(5):1043.e1-1043.e3. PubMed ID: 31784393 [TBL] [Abstract][Full Text] [Related]
57. [Depression caused by an anti-acne agent]. Robusto O Acta Med Port; 2002; 15(4):325-6. PubMed ID: 12525028 [TBL] [Abstract][Full Text] [Related]
58. YouTube as a source of dermatologic information on isotretinoin. Xiang L; Ravichandran S; Tamashunas N; Wan A; Mazmudar RS; Scott JF J Am Acad Dermatol; 2020 Aug; 83(2):653-655. PubMed ID: 31843656 [No Abstract] [Full Text] [Related]
59. Commentary on the Safety of Laser Hair Removal in Patients Receiving Systemic Isotretinoin for Acne Vulgaris. Singh G; Ortiz A; Saedi N Dermatol Surg; 2021 Nov; 47(11):1453-1454. PubMed ID: 34608082 [No Abstract] [Full Text] [Related]
60. A rare side-effect of systemic isotretinoin treatment: hoarseness. Kim HS; Park HJ; Lee JY; Cho BK J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1389-90. PubMed ID: 17062097 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]